BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38406544)

  • 1. B-cell maturation antigen expression and clinical features of plasmablastic lymphoma.
    Dong N; Zhang H; Song J; Mammadova J; Shah B; Saeed H; Gaballa S; Grajales-Cruz A; Isenalumhe L; Bello C; Sokol L; Pinilla J; Chavez J
    EJHaem; 2024 Feb; 5(1):285-289. PubMed ID: 38406544
    [No Abstract]   [Full Text] [Related]  

  • 2. BCMA CAR-T induces complete and durable remission in refractory plasmablastic lymphoma.
    Raghunandan S; Pauly M; Blum WG; Qayed M; Dhodapkar MV; Elkhalifa M; Watkins B; Schoettler M; Horwitz E; Parikh S; Chandrakasan S; Leung K; Bryson E; Deeb L; Kaufman JL; Worthington-White D; Alazraki A; Schecter JM; Madduri D; Jackson CC; Zudaire E; Taraseviciute-Morris A; Babich A; Nesheiwat T; Vogel M; Lendvai N; Pacaud L; Williams KM
    J Immunother Cancer; 2023 May; 11(5):. PubMed ID: 37137553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmablastic lymphoma: An update.
    Bailly J; Jenkins N; Chetty D; Mohamed Z; Verburgh ER; Opie JJ
    Int J Lab Hematol; 2022 Sep; 44 Suppl 1(Suppl 1):54-63. PubMed ID: 36074710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathologic features and abnormal signaling pathways in plasmablastic lymphoma: a multicenter study in China.
    Shi D; Gao L; Wan XC; Li J; Tian T; Hu J; Zhang QL; Su YF; Zeng YP; Hu ZJ; Yu BH; Li XQ; Wei P; Li JW; Zhou XY
    BMC Med; 2022 Dec; 20(1):483. PubMed ID: 36522654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Plasmablastic lymphoma presenting clinical symptoms similar to plasmablastic myeloma].
    Nakaya A; Nagate Y; Toda J; Yamashita Y; Hirose Y; Mori K; Shibayama H
    Rinsho Ketsueki; 2023; 64(4):260-264. PubMed ID: 37121769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unraveling the molecular landscape: a comparative analysis of PI3K and MAPK signaling pathways in plasmablastic lymphoma and diffuse large B-cell lymphoma with therapeutic implications.
    Mansoor A; Akhter A; Kamran H; Minoo P; Stewart D
    Hum Pathol; 2023 Nov; 141():102-109. PubMed ID: 37524252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokeratin expression in plasmablastic lymphoma - a possible diagnostic pitfall in the routine work-up of tumours.
    Huettl KS; Staiger AM; Horn H; Frontzek F; Goodlad JR; Tapia G; Rosenwald A; Klapper W; Fend F; Climent F; Castellvi J; Tzankov A; Dirnhofer S; Baptista MJ; Navarro JT; Anagnostopoulos I; Hartmann W; Lenz G; Ott G
    Histopathology; 2021 May; 78(6):831-837. PubMed ID: 33165992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Potential Therapeutic Targets for Plasmablastic Lymphoma Through Gene Expression Analysis: Insights into RAS and Wnt Signaling Pathways.
    Mansoor A; Kamran H; Akhter A; Seno R; Torlakovic EE; Roshan TM; Shabani-Rad MT; Elyamany G; Minoo P; Stewart D
    Mod Pathol; 2023 Aug; 36(8):100198. PubMed ID: 37105495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphoid neoplasms of the oral cavity with plasmablastic morphology-a case series and review of the literature.
    Bhattacharyya S; Bains APS; Sykes DL; Iverson BR; Sibgatullah R; Kuklani RM
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2019 Dec; 128(6):651-659. PubMed ID: 31494113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular histogenesis of plasmablastic lymphoma of the oral cavity.
    Gaidano G; Cerri M; Capello D; Berra E; Deambrogi C; Rossi D; Larocca LM; Campo E; Gloghini A; Tirelli U; Carbone A
    Br J Haematol; 2002 Dec; 119(3):622-8. PubMed ID: 12437635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasmablastic lymphoma of the stomach: an unusual presentation.
    Riaz H; Zaiden R; Khan M; Latif N
    Clin Adv Hematol Oncol; 2012 Jul; 10(7):477-80. PubMed ID: 22895293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CAR T Cells with Enhanced Sensitivity to B Cell Maturation Antigen for the Targeting of B Cell Non-Hodgkin's Lymphoma and Multiple Myeloma.
    Bluhm J; Kieback E; Marino SF; Oden F; Westermann J; Chmielewski M; Abken H; Uckert W; Höpken UE; Rehm A
    Mol Ther; 2018 Aug; 26(8):1906-1920. PubMed ID: 30078440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Plasmablastic lymphoma].
    Fernández-Álvarez R; Sancho JM; Ribera JM
    Med Clin (Barc); 2016 Nov; 147(9):399-404. PubMed ID: 27576534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploration and analysis of differentially expressed genes in Epstein-Barr virus negative and positive plasmablastic lymphoma.
    Liang Y; Wang H; Luo B
    Clin Transl Oncol; 2023 Oct; 25(10):2884-2891. PubMed ID: 36991219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmablastic Lymphoma. A State-of-the-Art Review: Part 1-Epidemiology, Pathogenesis, Clinicopathologic Characteristics, Differential Diagnosis, Prognostic Factors, and Special Populations.
    Bibas M
    Mediterr J Hematol Infect Dis; 2024; 16(1):e2024007. PubMed ID: 38223486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD3-positive plasmablastic lymphoma reported in two cases: A potential diagnostic caveat.
    Wong YP; Masir N; Chew MX
    Indian J Pathol Microbiol; 2021; 64(3):579-583. PubMed ID: 34341278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective Targeting of Multiple B-Cell Maturation Antigen-Expressing Hematological Malignances by Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor T Cells.
    Friedman KM; Garrett TE; Evans JW; Horton HM; Latimer HJ; Seidel SL; Horvath CJ; Morgan RA
    Hum Gene Ther; 2018 May; 29(5):585-601. PubMed ID: 29641319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasmablastic Lymphoma: A Review of Clinicopathologic Features and Differential Diagnosis.
    Harmon CM; Smith LB
    Arch Pathol Lab Med; 2016 Oct; 140(10):1074-8. PubMed ID: 27684979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An unusual case of paediatric plasmablastic lymphoma presenting with malignant effusion and the challenges in its diagnosis.
    Modi N; Khurana U; Mukhopadhyay S; Joshi D; Soni D; Chaudhary N; Malik S; Shet T
    Diagn Cytopathol; 2021 Oct; 49(10):E389-E394. PubMed ID: 34296830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-grade plasmablastic neoplasm of humerus in an HIV-negative patient, which was indeterminate between plasmablastic lymphoma and plasmablastic myeloma.
    Mondal SK; Bera H; Biswas PK; Mallick MG
    J Cancer Res Ther; 2011; 7(2):214-6. PubMed ID: 21768719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.